Auscandoc<p><a href="https://med-mastodon.com/tags/Vaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Vaccine</span></a> shows promise against aggressive <a href="https://med-mastodon.com/tags/breastcancer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>breastcancer</span></a> – WashU Medicine <a href="https://medicine.washu.edu/news/vaccine-shows-promise-against-aggressive-breast-cancer/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">medicine.washu.edu/news/vaccin</span><span class="invisible">e-shows-promise-against-aggressive-breast-cancer/</span></a> “Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a <a href="https://med-mastodon.com/tags/neoantigen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>neoantigen</span></a> DNA vaccine — for breast cancer patients.</p><p>The study, which found the vaccine to be well-tolerated and to stimulate the immune system, is available Nov. 14 in the journal Genome Medicine.”</p>